Enanta Pharmaceuticals (ENTA) Technical (Analysis) Reports Enanta Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Enanta Pharmaceuticals (ENTA)
Technical Analysis Report for USA stock ENTA Enanta Pharmaceuticals. Dated: 16 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ENTA Enanta Pharmaceuticals then click here. or read Experts views on Enanta Pharmaceuticals or Forecast & share price targets of Enanta Pharmaceuticals
Enanta Pharmaceuticals Opened at 13.28 and Closed at: 12.61, which is -5.87% of previous session's close. It moved within a range of 12.50 and 13.28
The session was a Bearish session with an average volume of 341100, which is 5.75% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 6 days back on short term averages
A Dead cross was found 2 days back on mid term averages
Support for tomorrow is 12.17 and resistance for tomorrow is 12.95
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 12.31, 12.02 resistance for tomorrow's hourly charts is 13.09, 13.58
10 Day SMA for Enanta Pharmaceuticals (ENTA) is 13.38 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Enanta Pharmaceuticals (ENTA) is 14.58 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Enanta Pharmaceuticals (ENTA) is 13.76 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 11.77 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Enanta Pharmaceuticals is 9.19 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Enanta Pharmaceuticals is at 14.58 and 200 DMA is at 9.19, while 50 DMA and 100 DMA are at 13.76 and 11.77 respectively
Enanta Pharmaceuticals (ENTA) moving average of 20 SMA is at 14.58 and 20 EMA is at 13.96
| Date | Closing Price | 20 SMA | 20 EMA |
| 16 Fri Jan | 12.61 | 14.58 | 13.96 |
| 15 Thu Jan | 13.35 | 14.66 | 14.1 |
| 14 Wed Jan | 13.84 | 14.74 | 14.18 |
| 13 Tue Jan | 13.13 | 14.79 | 14.22 |
| 12 Mon Jan | 12.91 | 14.87 | 14.34 |
| 09 Fri Jan | 13.11 | 14.93 | 14.49 |
Enanta Pharmaceuticals (ENTA) moving average of 50 SMA is at 13.76 and 50 EMA is at 13.48
| Date | Closing Price | 50 SMA | 50 EMA |
| 16 Fri Jan | 12.61 | 13.76 | 13.48 |
| 15 Thu Jan | 13.35 | 13.73 | 13.52 |
| 14 Wed Jan | 13.84 | 13.68 | 13.53 |
| 13 Tue Jan | 13.13 | 13.62 | 13.52 |
| 12 Mon Jan | 12.91 | 13.58 | 13.54 |
| 09 Fri Jan | 13.11 | 13.53 | 13.57 |
Enanta Pharmaceuticals (ENTA) moving average of 100 SMA is at 11.77 and 100 EMA is at 12.16
| Date | Closing Price | 100 SMA | 100 EMA |
| 16 Fri Jan | 12.61 | 11.77 | 12.16 |
| 15 Thu Jan | 13.35 | 11.73 | 12.15 |
| 14 Wed Jan | 13.84 | 11.69 | 12.13 |
| 13 Tue Jan | 13.13 | 11.64 | 12.1 |
| 12 Mon Jan | 12.91 | 11.59 | 12.08 |
| 09 Fri Jan | 13.11 | 11.55 | 12.06 |
Enanta Pharmaceuticals (ENTA) moving average of 200 SMA is at 9.19 and 200 EMA is at 10.8
| Date | Closing Price | 200 SMA | 200 EMA |
| 16 Fri Jan | 12.61 | 9.19 | 10.8 |
| 15 Thu Jan | 13.35 | 9.15 | 10.78 |
| 14 Wed Jan | 13.84 | 9.11 | 10.75 |
| 13 Tue Jan | 13.13 | 9.07 | 10.72 |
| 12 Mon Jan | 12.91 | 9.04 | 10.7 |
| 09 Fri Jan | 13.11 | 9 | 10.68 |
Laboratory Corporation has performed better than Enanta Pharmaceuticals in short term. You could have earned much better returns by investing in Laboratory Corporation, about 20.69% more returns!
Fresenius Medical has performed better than Enanta Pharmaceuticals in short term. You could have earned much better returns by investing in Fresenius Medical, about 6.69% more returns!
Davita Inc has performed better than Enanta Pharmaceuticals in short term. You could have earned much better returns by investing in Davita Inc, about 3.39% more returns!
Twist Bioscience has performed better than Enanta Pharmaceuticals in short term. You could have earned much better returns by investing in Twist Bioscience, about 43% more returns!
Theravance Biopharma has performed better than Enanta Pharmaceuticals in short term. You could have earned much better returns by investing in Theravance Biopharma, about 23.28% more returns!
Summit Therapeutics has performed better than Enanta Pharmaceuticals in short term. You could have earned much better returns by investing in Summit Therapeutics, about 13.09% more returns!
Sangamo Therapeutics has performed better than Enanta Pharmaceuticals in short term. You could have earned much better returns by investing in Sangamo Therapeutics, about 6.23% more returns!
Enanta Pharmaceuticals has performed better than Ultragenyx Pharmaceutical in short term. Holding Enanta Pharmaceuticals could be a better choice for now!
Enanta Pharmaceuticals has performed better than Ocular Therapeutix in short term. Holding Enanta Pharmaceuticals could be a better choice for now!
Novocure has performed better than Enanta Pharmaceuticals in short term. You could have earned much better returns by investing in Novocure, about 21.81% more returns!
Neogenomics Inc has performed better than Enanta Pharmaceuticals in short term. You could have earned much better returns by investing in Neogenomics Inc, about 22.71% more returns!
Merit Medical has performed better than Enanta Pharmaceuticals in short term. You could have earned much better returns by investing in Merit Medical, about 7.31% more returns!
Lipocine Inc has performed better than Enanta Pharmaceuticals in short term. You could have earned much better returns by investing in Lipocine Inc, about 178.21% more returns!
Enanta Pharmaceuticals has performed better than Kura Oncology in short term. Holding Enanta Pharmaceuticals could be a better choice for now!
Exelixis Inc has performed better than Enanta Pharmaceuticals in short term. You could have earned much better returns by investing in Exelixis Inc, about 16.48% more returns!
Enanta Pharmaceuticals has performed better than Curis Inc in short term. Holding Enanta Pharmaceuticals could be a better choice for now!
Cellectar Biosciences has performed better than Enanta Pharmaceuticals in short term. You could have earned much better returns by investing in Cellectar Biosciences, about 45.68% more returns!
Enanta Pharmaceuticals Technical analysis of indicators
Price action analysis of Enanta Pharmaceuticals (ENTA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Enanta Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Enanta Pharmaceuticals in short term and the sell signal is strong.
Enanta Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Enanta Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Enanta Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 13.37 and Enanta Pharmaceuticals ENTA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Enanta Pharmaceuticals ENTA stock. Volume based technical analysis of Enanta Pharmaceuticals ENTA stock is negative.
Enanta Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ENTA Enanta Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ENTA Experts View which covers a lot of information including buying and selling signals
ENTA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Enanta Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Enanta Pharmaceuticals (ENTA) Technical (Analysis) Reports Enanta Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


